Form 4: STERIS Executive Mary Clare Fraser Reports Equity Activity

STERIS plc SVP & Chief HRO Mary Clare Fraser reported the acquisition of restricted shares and stock options in a Form 4 filing.

Summary

• Mary Clare Fraser, SVP & Chief HRO of STERIS plc, acquired 3,009 ordinary shares on June 2, 2026.
• 591 shares were withheld to satisfy tax obligations related to the vesting of restricted stock, at a price of $209.76 per share.
• The reporting person was granted 10,492 employee stock options with an exercise price of $230.74, expiring on June 2, 2036.
• Following these transactions, the reporting person holds 14,627 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation practices with no material impact on company strategy or financial health.

Positives

• The executive continues to maintain a significant equity stake in the company, aligning interests with shareholders.
• The grant of stock options provides long-term incentive for the executive to drive company performance.

Negatives

• The withholding of 591 shares for tax purposes is a standard administrative action but reduces the net share acquisition.

Risks

• The value of the acquired options is dependent on the future market price of STERIS shares exceeding the $230.74 exercise price.

Future Outlook

The filing does not provide forward-looking financial guidance for the company, focusing solely on executive compensation and ownership changes.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation and equity ownership, common among large-cap medical device and sterilization services companies like STERIS.

Comparison to Industry Standards

• The use of restricted stock units and stock options as long-term incentive compensation is standard practice for executive officers in the healthcare equipment sector.
• Tax withholding via share surrender is a standard administrative procedure for equity-based compensation plans.

Stakeholder Impact

• Shareholders should note the continued alignment of executive interests through equity ownership.

Next Steps

• Vesting of restricted shares on various dates through June 2029.
• Exercisability of stock options beginning June 2027.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Compensation, Stock Options